Israel Englander Erytech Pharma S.A. Transaction History

Millennium Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.0 - $1.22 $0 - $22,854	-18,733 Reduced 60.82%	12,069 $0
Q1 2023 May 15, 2023	BUY	$0.34 - $1.38 $10,472 - $42,506	30,802 New	30,802 $30,000
Q1 2021 May 17, 2021	SELL	$6.74 - $12.01 $72,967 - $130,020	-10,826 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.14 - $10.2 $23,212 - $46,063	-4,516 Reduced 29.44%	10,826 $106,000
Q4 2019 Feb 14, 2020	SELL	$4.02 - $7.38 $9,004 - $16,531	-2,240 Reduced 12.74%	15,342 $112,000
Q3 2019 Nov 14, 2019	SELL	$4.23 - $7.0 $8,460 - $14,000	-2,000 Reduced 10.21%	17,582 $78,000
Q2 2019 Aug 15, 2019	SELL	$6.37 - $8.24 $895,698 - $1.16 Million	-140,612 Reduced 87.78%	19,582 $140,000
Q2 2019 Aug 14, 2019	BUY	$6.37 - $8.24 $875,951 - $1.13 Million	137,512 Added 606.26%	160,194 $5.31 Million
Q1 2019 May 14, 2019	SELL	$6.98 - $9.64 $6,980 - $9,640	-1,000 Reduced 4.22%	22,682 $172,000
Q4 2018 Feb 14, 2019	SELL	$5.54 - $9.23 $58,535 - $97,524	-10,566 Reduced 30.85%	23,682 $157,000
Q3 2018 Nov 14, 2018	SELL	$8.57 - $11.41 $35,994 - $47,922	-4,200 Reduced 10.92%	34,248 $299,000
Q2 2018 Aug 14, 2018	SELL	$11.17 - $21.41 $35,542 - $68,126	-3,182 Reduced 7.64%	38,448 $444,000
Q1 2018 May 15, 2018	SELL	$20.0 - $23.28 $38,740 - $45,093	-1,937 Reduced 4.45%	41,630 $874,000
Q4 2017 Feb 14, 2018	BUY	$17.93 - $30.3 $781,156 - $1.32 Million	43,567	43,567 $959,000

Ticker ERYP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,018,600
Market Cap $16.8M
Description
ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.